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Abstract: O-GlcNAcase catalyzes the cleavage of â-O-linked 2-acetamido-2-deoxy-â-D-glucopyranoside
(O-GlcNAc) from serine and threonine residues of post-translationally modified proteins. Two potent inhibitors
of this enzyme are O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate (PUGNAc)
and 1,2-dideoxy-2′-methyl-R-D-glucopyranoso[2,1-d]-∆2′-thiazoline (NAG-thiazoline). Derivatives of these
inhibitors differ in their selectivity for human O-GlcNAcase over the functionally related human lysosomal
â-hexosamindases, with PUGNAc derivatives showing modest selectivities and NAG-thiazoline derivatives
showing high selectivities. The molecular basis for this difference in selectivities is addressed as is how
well these inhibitors mimic the O-GlcNAcase-stabilized transition state (TS). Using a series of substrates,
ground state (GS) inhibitors, and transition state mimics having analogous structural variations, we describe
linear free energy relationships of log(KM/kcat) versus log(KI) for PUGNAc and NAG-thiazoline. These
relationships suggest that PUGNAc is a poor transition state analogue, while NAG-thiazoline is revealed
as a transition state mimic. Comparative X-ray crystallographic analyses of enzyme-inhibitor complexes
reveal subtle molecular differences accounting for the differences in selectivities between these two inhibitors
and illustrate key molecular interactions. Computational modeling of species along the reaction coordinate,
as well as PUGNAc and NAG-thiazoline, provide insight into the features of NAG-thiazoline that resemble
the transition state and reveal where PUGNAc fails to capture significant binding energy. These studies
also point to late transition state poise for the O-GlcNAcase catalyzed reaction with significant nucleophilic
participation and little involvement of the leaving group. The potency of NAG-thiazoline, its transition state
mimicry, and its lack of traditional transition state-like design features suggest that potent rationally designed
glycosidase inhibitors can be developed that exploit variation in transition state poise.
Introduction
The development of rationally designed potent glycoside
hydrolase inhibitors has been a topic of continuing research for
years and has more recently enjoyed a surge of interest due to
their increased uses as both research tools1,2 and as therapeutic
agents.3-5 Considerable efforts have been directed toward
preparing both potent6-8 and selective9-11 glycosidase inhibitors
using transition state (TS) mimicry as a guiding design
principle.7,8 The expectation that stable molecules resembling
the enzyme catalyzed transition state, in either their charge or
geometry, will be potent competitive inhibitors stems from a
proposal, made first by Pauling,12 that enzymes catalyze
reactions by binding interactions realized preferentially with the
transition state rather than with ground state (GS).12,13Such tight
binding stabilizes these fleeting transition state structures and
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thereby results in the enormous rate accelerations of up to 1019-
fold seen for the most proficient enzymes.14 On the basis of
this rate acceleration the theoretical limit for the dissociation
constant of a perfect transition state analogue can be estimated
to be approximately 10-22 M.14 Of course, stable transition state
analogues necessarily vary from genuine transition state struc-
tures having partial bonds, and therefore it is impossible to
capture all the potentially available binding energy using a stable
molecule. Despite this limitation, very potent transition state
analogues have been found for several different classes of
enzymes.15,16
For certain enzyme classes, extensive kinetic isotope effect
studies have been carried out that have enabled the definition
of geometric and electrostatic features of the transition state.17,18
Such studies have led to the development of very tight binding
inhibitors that are now clinical drug candidates.19 For glycosi-
dases, however, despite considerable synthetic efforts the very
best inhibitors rationally designed as transition state analogues
typically have no lower than nanomolar affinities.6-8 Although
highly detailed kinetic isotope effect studies of the glycoside
hydrolases are lacking, a significant body of data has accrued
that provides limited insights into the general features of
transition states found for these enzymes.20,21
Large and normal secondaryR-D kinetic isotope effect studies
suggest that these transition states have an sp2-hybridized
anomeric center with significant oxocarbenium ion-like char-
acter.21,22 A corollary of such presumed planar oxocarbenium
ion-like transition states is that the pyranose ring is expected to
assume a conformation in which the C-2, C-1, C-5, and O-5
atoms adopt a coplanar arrangement.20 Such limited kinetic
isotope effects, in conjunction with Brønsted analyses using
substrates having different leaving group abilities, have generally
suggested transition states in which the leaving group is largely
dissociated.21 Accordingly, the vast majority of rationally
designed glycosidase inhibitors exploit three principle design
features.6-8 First, an sp2-hybridized center is often installed at
C-1 of the pyranose ring to mimic the geometric requirements
of the putative planar oxocarbenium ion-like transition state.
Second, nitrogen is often incorporated in place of C-1 or O-5
to mimic the relative positive charge development at these
centers within the transition state. Third, and less commonly,
conformationally constrained inhibitors are used that force the
pyranose ring to adopt a transition state-like conformation.6,23-25
Many inhibitors are defined as transition state analogues by
virtue of the principles used in their design and their superficial
resemblance to predicted transition state structures. In only a
very few cases have efforts been made to define whether these
molecules are genuinely transition state analogues, simply
serendipitous binders, or actually ground state analogues. Here
we investigate the binding of two known potent inhibitors to
humanO-GlcNAcase; a family (for the classification of gly-
coside hydrolases see the CAZY database; http://afmb.cnrs-
mrs.fr/CAZY) 84 glycoside hydrolase catalyzing the cleavage
of O-linked 2-acetamido-2-deoxy-â D-glucopyranoside (O-
GlcNAc) from serine and threonine residues of post-transla-
tionally modified nuclear and cytoplasmic proteins.26,27 Our
objective being to gain insight into the design of potent tran-
sition state analogues as well as to evaluate whyO-(2-acet-
amido-2-deoxy-D-glucopyranosylidene)amino-N phenylcarb-
amate (PUGNAc, Figure 2,1a-g) based derivatives bearing
bulky N-acyl groups show weak selectivity28,29 for human
O-GlcNAcase over human lysosomalâ-hexosaminidase, while
analogous derivatives of 1,2-dideoxy-2′-methyl-R-D-glucopy-
ranoso-[2,1-d]-∆2′-thiazoline (NAG-thiazoline, Figure 2,
2a-g) show high selectivities.9
O-GlcNAcase uses a two-step catalytic mechanism involving
substrate-assisted catalysis9,30 to form a transient oxazoline
intermediate31 (Figure 1) that is broken down to liberate the
free sugar hemiacetal and the protein. This overall catalytic
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Figure 1. Catalytic mechanism used by O-GlcNAcase involves substrate-assisted catalysis. The first step of the reaction, cyclization, proceeds via attack
of the 2-acetamido carbonyl oxygen on the anomeric center to form a covalent bicyclic oxazoline intermediate. This step is facilitated by polarization of the
2-acetamido moiety by an enzymic carboxyl group most likely acting as a general base catalyst. Departure of the aglycone is facilitated by general acid
catalysis provided by another carboxyl group in the enzyme active site. In the second step, ring opening, the oxazoline intermediate is broken open by the
general base-catalyzed attack of a water molecule on the anomeric center and general acid catalysis facilitating departure of the amide group. Both steps
occur with inversion of stereochemistry at the anomeric center such that the overall reaction proceeds with net retention of stereochemistry.
mechanism is common to glycosidases from families 18, 20,
56, and 84, all of which have evolved two strategically
positioned carboxyl residues located within the active site that
play key catalytic roles.32-35 Asp174 and Asp175 have been
identified as the two key catalytic residues of humanO-
GlcNAcase.30,36 In the first step of the reaction, the cyclization
step, Asp174 directs and polarizes the 2-acetamido group to act
as a nucleophile and form the oxazoline intermediate.30 Asp175
meanwhile acts as a general acid, encouraging departure of the
aglycone leaving group.30 In the second step, ring-opening,
Asp174 facilitates departure of the 2-acetamido group, while
Asp175acts as a general base, promoting the attack of a molecule
of water to yield theâ-hemiacetal product.30 The structure of
the two transition states flanking the oxazoline intermediate have
been investigated through substrate structure-function studies9,30
andR-D kinetic isotope effects.31 These studies have suggested
an “exploded” SN1-like transition state in which both the leaving
group and nucleophilic carbonyl oxygen of the acetamido group
are distant from the anomeric center. Similar proposals have
been made for the mechanistically related family 20â-hexos-
aminidases.37 The most common interpretation of the geometric
and electrostatic structure of such transition states for enzymes
using substrate-assisted catalysis is that the transition states are
oxocarbenium ion-like with an sp2-hybridized anomeric center
and delocalized positive charge between the endocyclic ring
oxygen and the anomeric center.20-22
The two best characterized inhibitors ofO-GlcNAcase are
PUGNAc and NAG-thiazoline. PUGNAc, first prepared by
Vasella and co-workers,38 has been proposed to be a transition
state analogue39 by virtue of its sp2-hybridized anomeric center
which is thought to have geometric resemblance to an oxocar-
benium ion-like transition state (Figure 1). NAG-thiazoline, first
prepared by Knapp and co-workers,40 is a highly potent
competitive inhibitor of both the family 20â-hexosamin-
dases34,40and the family 84O-GlcNAcases.9 This molecule has
an obvious geometric resemblance to the oxazoline intermediate,
although it has been suggested it may bind tightly by virtue of
its resemblance to a geometrically related transition state.
Whether these two highly potent inhibitors ofO-GlcNAcase
are truly transition state analogues, however, has yet to be
determined.
Using a combination of linear free energy analyses, compu-
tational modeling studies, and X-ray crystallographic analysis
of enzyme-inhibitor complexes, we evaluate whether these two
inhibitors bind as transition state analogues, ground state
analogues, or serendipitous binders. New insights into the
structure of the transition state for theO-GlcNAcase catalyzed
hydrolysis of glycosides are gained and, by analogy, into those
of related enzymes using such a substrate-assisted catalytic
mechanism.
Results and Discussion
The successful application of the principles of enzymology
to the design of transition state analogues can be gauged by the
increasing numbers of potent, rationally designed, transition
state analogues. For many inhibitors few criteria, other than their
potency, are used to define them as transition state analogues.
In many cases, the designation of transition state analogue may
be inadvertently misused to describe opportunistic inhibitors that
simply exploit favorable binding situations within enzyme active
sites. In recent years there has only been limited progress in
developing still more potent transition state analogues of
glycoside hydrolase inhibitors. Studies directed at clarifying
which inhibitors are transition state analogues, however, have
proven value in improving our understanding of transition state
structures as well as in the iterative design of improved transition
state analogues. We therefore have undertaken studies to define
the mode of binding of two well-characterized inhibitors of
humanO-GlcNAcase: NAG-thiazoline and PUGNAc.
Both NAG-thiazoline and PUGNAc are potent inhibitors of
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Figure 2. Series of inhibitors and substrates used to study transition state analogy of PUGNAc and NAG-thiazoline.
O-GlcNAcase (Table 1) and bind nearly 240 000-fold more 
tightly than the ground state inhibitor methyl 2-acetamido-2-
deoxy-â-D-glucopyranoside 4a (KI ) 11 mM, Table 1). Potent 
inhibition alone, however, is not a good measure of transition 
state analogy, and several other more rigorous approaches have 
been advanced.15,41-44 Arguably, the most rigorous approach 
to establishing transition state analogy has been to use free 
energy correlations between inhibitor binding and transition state
 
stabilization.15,44 Using this method to distinguish whether an
inhibitor is a transition state analogue, ground state analogue,
or simply a fortuitous binder involves systematic modification
of the inhibitor at one position and determining the resulting
changes inKI values. Analogous structural changes are also
made within the substrate, andkcat/Km values are determined,
since this parameter informs on the structure of the first
transition state reached along the reaction coordinate. The
inverse logarithm of these values provides free energy terms
that, when correlated to each other in a plot of logKI versus
log KM/kcat, may yield one of several patterns.15,44,45The proper
interpretation of these linear free energy diagrams rests on
several practical assumptions:44 (1) the chemical step having
the transition state mimicked by the inhibitors must be rate
limiting for the reaction, (2) the intrinsic reactivity of the
substrates must not significantly change as a result of the
modifications, and (3) variation of the substituent should not
affect binding to the enzyme of the unmodified regions of either
the substrate or inhibitor. Once these requirements are satisfied
a strong correlation with a slope of 1 reveals the inhibitor is a
transition state analogue. This interpretation stems from the
expectation that changes made to a bona fide transition state
analogue should evoke equivalent changes in the energy of the
actual transition state when introduced within the substrate.46,47
Conversely, scattered plots having weak correlations suggest
the inhibitor is a poor transition state analogue or a fortuitous
binding inhibitor.7 Ground state mimics, on the other hand, are
best revealed by strong correlations having a slope of 1 between
log KI of the inhibitor and logKS values for binding of the
substrate (logKI for a ground state analogue or logKM for
enzymes with a rapid equilibrium substrate binding step may
also be used).
It is noteworthy that in two closely related glycosidases from
family 13, correlations of logKI versus logKM/kcat have yielded
slopes other than 1 and these have been interpreted in entirely
different ways.24,25 These two studies, however, have been
carried out using enzymes in which mutations have been made
at several different residues within their active sites. It therefore
seems prudent to make systematic structural variations at only
one site. The best approach, first described by the Bartlett
group,15 is to make a series ofsmallstructural perturbations to
the inhibitor atonesite since these are most likely to report in
a sensitive manner on changes in the differences between the
actual transition state and the putative transition state mimic.
For O-GlcNAcases, we know that theN-acyl group of the
substrate is critically involved in catalysis and must undergo
conformational, electrostatic, and positional variation within the
active site of the enzyme on proceeding from the ground state
to the transition state.9,31 We speculated that modifications of
this group would report clearly on the transition state structure
for these enzymes and that derivatives of PUGNAc (1) and
NAG-thiazoline (2), both previously synthesized within our
laboratory, would be useful probes.9,28 The structural changes
within these inhibitors are small increases in the volume of the
alkyl group of theN-acyl moiety and they give rise toKI values
varying by over five orders of magnitude when assayed against
humanO-GlcNAcase (Table 1).28 Such a wide variation inKI
values is beneficial for establishing a meaningful correlation.
With these molecules already in hand, we then prepared
(Scheme 1) the requisite series of substrates with analogous
modifications to theN-acyl group and measured the second-
order rate constants for humanO-GlcNAcase catalyzed hy-
drolysis of these compounds (Table 1). Satisfying the first
requirement of the transition state analogy approach (vide supra),
we have previously shown, using a combination of kinetic
isotope effects31 and a series of substrates bearing different
leaving groups,9,30 that the second-order rate constant for
substrates bearing the 4-methylumbelliferyl leaving group
reflects the first chemical step. The second requirement of this
approach is fulfilled since the spontaneous hydrolysis rates of
these substrates are indistinguishable within error. Due to
limitations in the solubility of these substrates, however, we
were unable to obtain reliableKS or evenKM values making
correlations withKS or KM values impossible. A series of methyl
glycosides (Figure 2,4a-g) was therefore also prepared
(Scheme 1) as simple ground state substrates and were tested
as competitive inhibitors to obtain inhibition constants (Table
1) that are taken to be equivalent to true dissociation constants.
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Table 1. Kinetic Data Determined Using Human O-GlcNAcase for the Three Series of Inhibitors and the Series of Substrates
PUGNR GlcNR-THZ





-CH3 0.046 1 0.07 1 11 0.13
-CH2CH3 1.2 1 0.12 270 11 0.15
-(CH2)2CH3 2.5 11 0.25 1500 21 0.19
-(CH2)3CH3 40 6 1.5 3100 70 1.8
-(CH2)4CH3 220 g5 57 100 205 1.8
-CH(CH3)2 9 2 1.6 700 147 5.0
-CH2CH(CH3)2 190 g6 5.7 190 224 110
Scheme 1 a
a (i) AcBr, heat; (iia) pyridine, MeOH; (iib)(a) acetone, 4-MU, Na 4-MU;
(b) K2CO3, Et2O; (c) HCl; (iii) RCOCl, Et3N, DCM; (iv)(a) NaOMe, MeOH;
(b) 20:1 MeOH:acetic acid.
Testing parent glycoside4 as a representative member of these
ground state inhibitors revealed, as expected, a pattern of
competitive inhibition (Figure 3) and validated their use as
ground state analogues binding within theO-GlcNAcase active
site. Together, these four sets of compounds allowed us to
delineate the nature of the inhibition of humanO-GlcNAcase
by NAG-thiazoline and PUGNAc.
Correlations of logKI values for the series of NAG-thiazoline
derivatives (Figure 2,2a-g) with the corresponding logarithm
of the inverse second-order rate constantsKM/kcat for the
O-GlcNAcase catalyzed hydrolysis of a series of 4-methylum-
belliferyl glycoside substrates (Figure 2,3a-g) reveals a strong
correlation (r2 ) 0.98) with a slope of 0.97( 0.06 (Figure 4D).
This correlation indicates that the incremental differences in
binding energy related to the elaboration of the thiazoline ring
with aliphatic chains of increasing length are nearly identical
to those perturbations observed for the transition state of the
enzyme catalyzed hydrolysis of the substrates bearing analogous
changes. Correlations of logKI values with the corresponding
logarithm of the inhibition constants (logKI(GS)) for the ground
state inhibitors showed no clear correlation (Figure 4C). These
two patterns are very similar to those observed by Bartlett and
co-workers,15,48which they used to show that phosphonamidates
are transition state analogues for the zinc peptidases. Together
these data strongly support the proposed mechanism involving
substrate-assisted catalysis from the acetamido group and re-
veal NAG-thiazoline as a good transition state mimic for
O-GlcNAcase catalyzed glycoside hydrolysis.
Using this approach, it is possible only to comment on the
transition state resemblance in regions where the inhibitor varies
in structure from the substrate. The specific structural features
probed by NAG-thiazoline encompass the entire thiazoline ring,
including the position of all associated atoms including C-1 and
C-2 of the pyranose ring. Notably, C-1 of NAG-thiazoline is
an sp3-hybridized carbon center rather than an sp2-hybridized
center or basic nitrogen, features that are often assumed to be
essential features of transition state mimics for glycoside
hydrolases. The two best studied iminosugar inhibitors are the
isofagomine class, wherein C-1 is replaced with nitrogen and
the endocylic ring oxygen with a methylene unit, and the
nojirimycin class of inhibitors, wherein the endocylic ring
oxygen is replaced by a nitrogen atom. Both of these inhibitors
have been proposed to be transition state mimics although more
recent experimental data suggest that, at least for some enzymes,
this is not the case. Indeed, in a crystallographic complex of
GalNAc-isofagomine bound to a family 20â-hexosamindase
that uses substrate-assisted catalysis, it was observed that the
protonated nitrogen engaged in an adventitious electrostatic
interaction with the general acid/base catalytic residue.49 For
nojirimycin, scattered linear free energy data was observed for
two relatedR-glucosidases, suggesting that this inhibitor is an
adventitious binder to the two enzymes studied.7,25
For the series of PUGNAc derivatives a poor correlation (r2
) 0.73, Figure 4B) with a slope of 1.07( 0.29 was observed
in a plot of log KI values of the inhibitor versus logKM/kcat
values for the series of glycoside substrates. As well, a poor
correlation is observed between logKI values and logKI(GS)
values for the ground state inhibitors (Figure 4A). Accordingly,
the scatter within both of these correlations indicates that
incremental changes of theN-acyl chain of the parent compound
are not viewed in a similar manner within the active site of the
enzyme as the incremental elongation of theN-acyl chain of
the substrate, indicating that PUGNAc is either a poor mimic
of the O-GlcNAcase-catalyzed transition state or simply a
fortuitous binder. Consistent with this interpretation, Bartlett
has described scatter of the data as an indication that the inhibitor
may not closely resemble the transition state.44
In the context of the traditional design principles used in
developing transition state analogue inhibitors of glycosidases,
the apparent weak transition state analogy of PUGNAc is
surprising. The trigonal anomeric center found within PUGNAc
is often considered to be a vitally important feature, and many
potent inhibitors contain such a moiety. It is worth noting that
NAG-thiazoline, which lacks all of the key design features of
transition state analogues, is an equally potent inhibitor as
PUGNAc. NAG-thiazoline may therefore mimic a transition
Figure 3. Inhibition of humanO-GlcNAcase using ground state substrate
methyl 2-acetamido-2-deoxy-â-glucopyranoside. Inhibition ofO-GlcNAcase
catalyzed hydrolysis ofpNP-GlcNAc by the methyl glycoside (4a) shows
a pattern of competitive inhibition. The concentrations of4a (mM) used
were 85.0 (4), 42.5 (9), 11.0 (0), 5.5 (b), and 0.0 (O).
Figure 4. Comparison of transition state analogy free energy diagrams
for NAG-thiazoline and PUGNAc derivatives. (A, top left) Comparison of
PUGNAc series of inhibitors (1a-g) KI with methyl glycoside series
(4a-g) KI. (B, top right) Comparison of PUGNAc series of inhibitors
(1a-g) KI with substrate (3a-g)KM/kcat. (C, bottom left) Comparison of
thiazoline series of inhibitors (2a-g) KI with methyl glycoside series
(4a-g)KI. (D, bottom right) Comparison of thiazoline series of inhibitors
(2a-g) KI with substrate (3a-g)KM/kcat.
(48) Phillips, M. A.; Kaplan, A. P.; Rutter, W. J.; Bartlett, P. A. Biochemistry 
1992, 31, 959-963.
(49) Mark, B. L.; Vocadlo, D. J.; Zhao, D.; Knapp, S.; Withers, S. G.; James,
M. N. J Biol. Chem. 2001, 276, 42131-42137.
 
state that is significantly different than the canonical oxocar-
benium ion-like transition state that is widely perceived to be
found along the reaction coordinate of glycoside hydrolases.
In view of this possibility we considered previous results in
this new context. The large secondaryR-deuterium kinetic
isotope effects (RD-KIE) of 1.14( 0.02 measured previously31
with humanO-GlcNAcase suggests that the enzyme stabilized
transition states have oxocarbenium ion-like character with
significant sp2-character at the anomeric center. Interpreting this
KIE as revealing a strict trigonal geometry at the anomeric center
in the transition state is complicated, however, as underscored
by studies of known SN2 reactions of the methoxymethyl model
system. Depending on the nature of the incoming nucleophile,
RD-KIE values traditionally held to be consistent with either
SN1 (kH/kD ) 1.18) or SN2 (kH/kD ) 0.99) were observed.50
Further complicating matters is that equilibrium isotope binding
effects have been observed in several cases where deuterium is
present at the anomeric center.51 Accordingly, in the absence
of other supporting heavy atom isotope effects at the reaction
center, interpreting the magnitude ofRD-KIE values at acetal
centers is difficult and cannot be used to discern the extent of
nucleophilic participation.52 Therefore, it seems equally pos-
sible that theRD-KIE values determined may reflect a non-
planar transition state having greater nucleophilic participation
and correspondingly less p-orbital character at the anomeric
center.
Such differences in the extent of nucleophilic participation
and involvement of the leaving group have been well-
documented for theN-ribosyl hydrolases and have developed
with the support of X-ray crystallographic analyses of enzyme-
inhibitor complexes into the concept of transition state poise.
The transition state poise is defined by the bond orders between
the anomeric center and both the leaving group and nucleophile,
which can vary significantly as a function of the position of
C-1 along the reaction coordinate. In this context the glycoside
hydrolases,53 like the N-ribosyl hydrolases, appear to use an
electrophilic migration mechanism54 for which the reaction
coordinate diagram can be defined by the motion of the
anomeric carbon and where the total bond order between the
anomeric center, nucleophile, and leaving group is significantly
less than 1. Within crystallographically visualized Michaelis
complexes ofâ-D-glycoside hydrolases33,55the anomeric carbon
typically adopts a positionaboVe the plane of the pyranose ring
with the exocyclic oxygen hydrogen bonding to the general acid
catalytic group. Within the newly formed intermediate, the
anomeric carbon is now positionedbelow the plane of the
pyranose ring bonded to the nucleophile. ForO-GlcNAcase,
this nucleophile is the carbonyl oxygen of the acetamido group.
The transition state must accordingly resemble a structure sitting
somewhere along this pathway defined by these two end points
and not necessarily, as widely believed, equidistant between
them as would be found for an oxocarbenium ion.
Taft-like linear free energy analyses (logkcat/KM versusσ*)
of theO-GlcNAcase catalyzed hydrolysis ofN-fluoroacetamido
glycosides have strongly implicated the acetamido group in
nucleophilic participation at the transition state of the rate
determining chemical step.9,31 Furthermore, the linear free
energy analyses we describe here indicate that NAG-thiazoline
is a transition state analogue, an observation also consistent with
nucleophilic participation since the anomeric carbon and the
thiazoline sulfur atom are only 1.85 Å apart from each other.
However, whether NAG-thiazoline geometrically resembles the
transition state along the reaction coordinate, some point along
the reaction coordinate that is close to this saddle, or that the
enzyme catalyzed reaction is DN + AN with a short-lived, yet
discrete oxocarbenium ion, as has been suggested forâ-galac-
tosidase by Richard and co-workers,56 currently remains untested
in any glycoside hydrolase.
Assuming the transition state resembles NAG-thiazoline, as
suggested by the free energy analyses, one can approximate the
bond orders to both the leaving group and nucleophile. By
assuming the interatomic distance between C-1 and the carbonyl
oxygen in the transition state is 1.85 Å (the length of the C-S
bond length within NAG-thiazoline), a Pauling bond order of
0.26 to the nucleophile can be calculated. The Brønsted analyses
and theRD-KIE values previously measured for humanO-
GlcNAcase suggest little involvement of the leaving group in
the transition state. On these bases and the crystallographic
analyses of theBacteroides thetaiotaomicron O-GlcNAcase
homologue in complex with NAG-thiazoline, we estimate the
bond order to the leaving group is nearly 0 (0.01). In this
structure, a molecule of water sits approximately 2.8 Å above
the anomeric carbon in a position that is expected to be occupied
by the glycosidic oxygen of the substrate within the Michaelis
complex, and it is held in position by a hydrogen bond to the
enzymic general base catalyst.57 These data, in combination with
other studies of the glycosidase mechanism, suggest that human
O-GlcNAcase possesses an oxocarbenium ion-like transition
state which is significantly stabilized by nucleophilic participa-
tion of the 2-acetamido group. This nucleophilic participa-
tion, in combination with the action of the catalytic residue
hydrogen bonding with the amide nitrogen (Asp174 in human
O-GlcNAcase and Asp242 in the B. thetaiotomicronâ-glu-
cosaminidase), delocalizes excess positive charge away from
the C-1-O-5 region of the pyranose and on into the oxazoline
ring. Such a dissociative transition state is consistent with the
previously described Taft analyses,9,57kinetic isotope effects,31
and the free energy analyses we detail here. It is also reminiscent
of those determined empirically forN-ribosyl transferases using
a DNAN mechanism but most likely involving slightly greater
nucleophilic participation.17,58
To gain greater insight into the basis by which NAG-
thiazoline mimics the transition state whereas PUGNAc does
not, we carried out crystallographic analyses of the selec-
tive O-GlcNAcase inhibitor, NButGT, complexed to a bac-
terial homologue of humanO-GlcNAcase. ThisB. thetaioto-
micron â-glucosaminidase is an excellent model of human
(50) Knier, B. L.; Jencks, W. P.J. Am. Chem. Soc.1980,102, 6789-6798.
(51) Lewis, B. E.; Schramm, V. L.J. Am. Chem. Soc.2003,125, 4785-4798.
(52) Huang, X. C.; Tanaka, K. S. E.; Bennet, A. J.J. Am. Chem. Soc.1997,
119, 11147-11154.
(53) Vocadlo, D. J.; Davies, G. J.; Laine, R.; Withers, S. G.Nature2001,412,
835-838.
(54) Fedorov, A.; Shi, W.; Kicska, G.; Fedorov, E.; Tyler, P. C.; Furneaux, R.
H.; Hanson, J. C.; Gainsford, G. J.; Larese, J. Z.; Schramm, V. L.; Almo,
S. C.Biochemistry2001,40, 853-860.
(55) Sulzenbacher, G.; Driguez, H.; Henrissat, B.; Schulein, M.; Davies, G. J.
Biochemistry1996,35, 15280-15287.
(56) Richard, J. P.; Huber, R. E.; Heo, C.; Amyes, T. L.; Lin, S.Biochemistry
1996,35, 12387-12401.
(57) Dennis, R. J.; Taylor, E. J.; Macauley, M. S.; Stubbs, K. A.; Turkenburg,
J. P.; Hart, S. J.; Black, G. N.; Vocadlo, D. J.; Davies, G. J.Nat. Struct.
Mol. Biol. 2006,13, 365-371.
(58) Scheuring, J.; Berti, P. J.; Schramm, V. L.Biochemistry1998,37, 2748-
2758.
O-GlcNAcase since it too processesO-GlcNAc modified
proteins and also has striking sequence conservation when
compared to the humanO-GlcNAcase. The structure of the
B. thetaiotaomicronGH84 O-GlcNAcase, in complex with
NButGT was solved at a resolution of 2.25 Å by molecular
replacement (Table 2). The structure crystallized in aC2 space
group (see methods) in which two molecules ofBtGH84 lie in
the asymmetric unit in the same orientation separated by a
translation-only vector of 0, 0, 0.5. TheBtGH84 structure can
be traced from residue 4 of the mature protein through to residue
589, with two short breaks in molecule B from 51 to 53 and
from 455 to 456. The C-terminal “CBM32-like”â-sheet domain,
which was partially ordered in the original native structure
solution, is completely disordered in this crystal form and could
not be modeled. We compared the structure of this complex
with a previously determined structure of NAG-thiazoline bound
to the same enzyme57 as well as to a complex of PUGNAc
bound within the active site of aClostridium perfringens
homologue39,59 of O-GlcNAcase. Gratifyingly, NButGT and
NAG-thiazoline bind identically within the active site, and the
pyranose ring of the inhibitors within both complexes can be
overlaid exactly (data not shown). We find the only difference
between the two structures is where electron density corre-
sponding to the alkyl chain of NButGT extends into an active
site pocket (Figure 5A) that has been previously predicted to
accommodate such bulkier groups.9,57 The confirmation of
identical binding modes for the parent inhibitor and NButGT
is important in the context of the transition state analogy studies
described here since it satisfies the third implicit assumption of
the approach that analogous inhibitors bind in the same
orientation.
It has been noted previously by us that derivatives of
PUGNAc having bulkyN-acyl groups show weak selectivity
toward humanO-GlcNAcase over humanâ-hexosaminidase,28,29
while the analogous NAG-thiazoline derivatives show high
selectivities.9 In an effort to better understand the molecular
basis for these differences in selectivity, we decided to compare
the binding modes of NButGT and PUGNAc by overlaying the
structures of these two inhibitors bound to theO-GlcNAcase
homologues (Figure 5B). The molecular basis for this discrep-
ancy in selectivity must stem from structural differences between
these molecules and how they interact with the active site of
humanO-GlcNAcase.
There are several obvious structural differences between
NAG-thiazoline and PUGNAc. The first, and most obvious
difference is that PUGNAc bears a phenyl carbamate moiety
which is absent in NAG-thiazoline. This substituent extends out
from the active site and engages in several interactions that are
not found for NAG-thiazoline. The exocyclic oxime nitrogen
of PUGNAc hydrogen bonds with the general acid/base catalytic
group (Asp175 within humanO-GlcNAcase30 and Asp243 within
the B. thetaiotaomicronâ-glucosaminidase57), and the phenyl
group of PUGNAc also engages in several hydrophobic and
stacking interactions with residues in the aglycon binding site.
It is interesting to note thatN-acetylglucosamino-1,5-lactone
oxime (LOGNAc), which lacks the phenyl carbamate group of
PUGNAc, binds 30-fold more poorly26 than PUGNAc, providing
an indication of the importance of these serendipitous inter-
actions. A second structural difference between the two inhibi-
tors is that the hybridization at the anomeric center varies. This
(59) Ficko-Blean, E.; Boraston, A. B.Acta Crystallogr., Sect. F: Struct. Biol.
Cryst. Commun.2005,61, 834-836.
Table 2. Data Collection and Refinement Statistics for the






a, b, c (Å) 185.1, 51.7, 172.8
R, â, γ (deg) 90.0, 100.1, 90.0
wavelength 0.9930
resolution (Å) 40-2.25 (2.33-2.25)a
Rsym or Rmerge 0.086 (0.47)
I/σ(I) 18 (3)















bond lengths (Å) 0.023
bond angles (deg) 1.99
a Highest-resolution shell is shown in parentheses.
Figure 5. Structural analyses of the binding of NButGT toBtGH84 and
its comparison to binding of PUGNAc toCfGH84. (A) Observed electron
density for the NButGT along with its flanking residues. The map shown
is a 2Fobs-Fcalc electron density map contoured at 1σand is shown in
divergent (“walleyed”) stereo. (B) Structural overlap of theBtGH84 NButGT
complex (ligand, gray; protein, green) with the PUGNAc complex of the
Clostridium perfringensGH84 enzyme39 (yellow). The overlap was
optimized using the main-chain protein atoms only, in a radius of 15 Å of
the ligands, using the program QUANTA (Accelrys, San Diego, CA). This
figure was drawn using MOLSCRIPT63 and BOBSCRIPT.64
variation has an impact on the preferred conformation of the
pyranose ring; for PUGNAc the pyranose ring adopts a4E
conformation enforced, in part, by the sp2-hybridized anomeric
center, whereas NButGT sits in a4C1 chair that is slightly
distorted toward the4E conformation due to the rigidity of the
thiazoline ring. The structural consequence of these variations
is that the substituents of the pyranose ring, particularly the
3-and 4-hydroxyl groups, adopt subtly different orientations.
Such apparently minor differences in the position of both ring
and substituent atoms can have pronounced effects on both van
der Waals interactions and hydrogen bonds. A third obvious
structural difference is that theN-acyl group of PUGNAc is
free, while NAG-thiazoline’s orientation is locked. This differ-
ence also results in important variations in the pKa of the
protonated nitrogen at the 2-position of the pyranose ring that
will be discussed in greater detail in context of the computational
studies (vide infra). The thiazoline ring is nestled between two
tryptophan residues which presumably serve to accurately
position the acetamido group of the substrate and stabilize the
positive charge that develops at the transition state during
formation of the oxazoline ring. Not only does the thiazoline
ring engage in stacking interactions with these residues, but it
also orients the alkyl substituent of the inhibitors. As seen in
the structural comparison, (Figure 5), the alkyl substituent of
NButGT is pointing directly down the active site cavity, whereas
the N-acetamido group of PUGNAc is pointed at a slightly
different angle. Consistent with this structural view, human
O-GlcNAcase is better able to cope with elongation of the
aliphatic chain of NAG-thiazoline derivatives as compared to
analogous derivatives of PUGNAc (Table 1). Because van der
Waals forces are powerfully distance-dependent, this apparently
small difference may account for the significant differences in
selectivity observed by us between the derivatives of these two
families of inhibitors.
These crystallographic analyses primarily furnish details of
the geometric features mediating interactions in the enzyme-
inhibitor complexes but do not provide great insight into
transition state structure nor the electrostatic features of the
inhibitors and reaction coordinate species. We therefore reasoned
that further insight into the potency, transition state analogy,
and selectivity of both NAG-thiazoline- and PUGNAc-derived
compounds toward humanO-GlcNAcase could be gained from
a comparison of their molecular electrostatic potential surfaces
(MEPs) with that of the enzyme-bound intermediate or, better
still, the enzymic transition state. Work by the Schramm group
has shown that the similarity of transition states and inhibitors
may be probed qualitatively and quantitatively using MEPs.60
Accordingly, we modeled both inhibitors, PUGNAc-analogue
I and NAG-ThiazolineII, as well as three species found along
the reaction coordinate for the cyclization step (Figure 6C,
bottom structures in color): an intact methyl glycoside ground
stateIII, the transition stateIV we predict on the basis of the
TS analogy studies featuring a distorted oxazoline in which the
C-1 carbonyl oxygen bond distance was constrained to the C-S
bond distance within NAG-thiazoline,61 and last the oxazoline
intermediateV (Figure 6C, bottom structures in color). It is
important to note that these species are expected to provide a
reasonable qualitative, though not quantitatively accurate,
description of the reaction coordinate.
A comparison of our transition state modelIV and the
oxazolineV demonstrates that C-O bond extension is associ-
ated with both increased planarity about the anomeric carbon
center as well as a contraction of the endocyclic C-1-O-5 bond.
The most striking difference between oxazolineV and transition
state modelIV, however, is the build-up of positive charge,
not only at the anomeric carbon center but also on the anomeric
proton. This redistribution of charge is much more apparent than
other changes centered about, for example, the endocyclic ring
oxygen or within the oxazoline ring.
To afford a careful evaluation of this difference, we verified
that this change in the MEP at the anomeric center was
independent of the protonation state of oxazolineV by calculat-
ing similar MEPs for the associated oxazolinium ion, thiazo-
(60) Bagdassarian, C. K.; Schramm, V. L.; Schwartz, S. D.J. Am. Chem. Soc.
(61) Using a different distance constraint for the model involving the distance
from the anomeric center to the 2′-carbon of the thiazoline ring leads to an
even tighter TS model with respect to the distance between the anomeric
center and the nucleophilic oxygen atom. This constraint allows the bond
between the 2′-carbon and the nucleophilic oxygen bond to flex with the
result that within the model it adopts a length greater than that found within
the model of the oxazoline intermediate; a result that is inconsistent with
the bond having an order between 1 and 2.
Figure 6. Simplified reaction coordinate for humanO-GlcNAcase-catalyzed
â-glucosaminide hydrolysis showing the MEPs for PUGNAc-analogueI
(modeled with methyl rather than phenyl) and NAG-thiazolineII as
well as ground stateIII , transition state modelIV, and oxazolineV.
NAG-thiazolineII is shown to share structural and electrostatic properties
of both transition state modelV and oxazolineIV. PUGNAc-analogueI is
shown to share significant electrostatic properties with ground state
III, although it does display some transition state-like conformational
properties. MEPs (which all share a common scale) are shown projected
onto the 0.04 electrons/Å3 isodensity surface. Stick models of the calculated
structures used to generate the MEPs are provided in the Supporting
Information.
1996, 118, 8825-8836.
linium ion, and oxazolinium ion-based transition state model
(in which the anomeric C-O bond length of the oxazolinium
ion was constrained to that found in the thiazolinium ion). These
MEPs may be found in the Supporting Information. A com-
parison of MEPs for the oxazolinium ion and the oxazolinium
ion-based transition state model showed similarly significant
changes in charge distribution on the anomeric carbon and
hydrogen atoms (with an increase in positive character in the
transition state model).
An analysis of the structure and MEP of thiazolineII reveals
that it mimics some aspects of oxazolineV while in other aspects
it more closely resembles the transition state modelIV. The
hexopyranose ring conformations of oxazolineV, thiazolineII,
and transition state modelIV are all subtly different. The model
used for the reactivity of many glycosidases is one in which
electrophilic migration of the anomeric carbon center enforces
a conformational itinerary following the1S3-4H3-4C1 path from
Michaelis complex to enzyme-bound intermediate (Figure 6A).
A comparison of our optimized structures indicates that, whereas
the pyranose ring of transition state modelIV is best described
as a4H3 conformation and that of NAG-thiazoline as adopting
a 4C1 conformation, oxazolineV is best described as adopting
a 4H5 conformation. This conformation is a result of C-3-
C-2-C-1-O-5 coplanarity favored by formation of the five-
membered oxazoline ring which induces strain in the pyranose
ring. Although the precise conformational itinerary traveled
along the reaction coordinate is uncertain, it seems likely that
the less strained4C1 conformation of thiazolineII lies confor-
mationally closer to our transition state model.
Although NAG-thiazolineII bears a significant geometric
resemblance to transition state modelIV, a comparison of the
MEPs for the three species under consideration reveal some
subtle differences. The larger van der Waals radius of sulfur
compared to oxygen is readily apparent when the MEPs are
visualized. The potential surrounding the sulfur atom is also
appreciably less negative than that surrounding the oxygen atom
of either oxazolineV or transition state modelIV. Furthermore,
the potential distribution around the anomeric carbon and
hydrogen atoms of thiazolineII most closely resembles that of
oxazolineV when compared to that of transition state model
IV.
The structural properties of thiazolineII and its MEP indicate
that it is likely to be a reasonable mimic of a species that lies
on the reaction coordinate between the region of the enzymic
transition state and the enzyme-bound intermediate. PUGNAc-
analogueI , in contrast, displays a number of markedly different
structural and electrostatic characteristics from oxazolineV and
the transition state modelIV. The hexopyranose ring of
PUGNAc-analogueI adopts a4E conformation and, as such, is
a marginally good mimic of the conformation of transition state
modelIV . In a number of critical respects, however, PUGNAc-
analogueI is an unsatisfactory mimic of either the oxazolineV
or its preceding transition state. PUGNAc-analogueI fails to
capture any significant bonding between theN-acetamido moiety
and the anomeric carbon center: as indicated previously, this
interaction is a critical component of the reaction pathway at
the transition state.30 More critically, the MEP of PUGNAc-
analogueI indicates that there is significantly more negative
potential in the region of the anomeric carbon atom. This
negative potential is in striking contrast with the more positive
potential observed in oxazolineV, thiazoline II, and the
transition state analogueIV. In this respect PUGNAc-analogue
I is significantly more substrate-like (structureIII ). The marked
changes in charge at this center along the reaction coor-
dinate are likely to be a significant target forselectiVe transition
state stabilization by humanO-GlcNAcase, so any failure to
mimic transition state charge at this center is likely to hinder
the ability of PUGNAc and derivatives to act as transition state
analogues.
Another notable difference between NAG-thiazoline and
PUGNAc is that the polarizing residue (Asp174 in human
O-GlcNAcase30 and Asp242 in the B. thetaiotaomicronâ-glu-
cosaminidase57) is likely to engage in a much stronger interaction
with oxazolineIV and thiazolineII as compared to PUGNAc-
analogueI . As noted previously,30 the pKa of the nitrogen atom
will change during the cyclization step from around 15, for an
amide proton, to a pKa of about 5.5, the value found for
the 2-methyl-∆2-oxazolinium ion.62 The pH-rate profile
(log(KM/kcat) vs pH) for the hydrolysis ofp-nitrophenylâ-N-
acetylglucosaminide allows us to assign a macroscopic pKa value
of approximately 5.0 to Asp174.30 The pKa of Asp174, therefore,
much more closely matches those of the conjugate acids of
thiazolineII and oxazolineIV than that of PUGNAc-analogue
I. Because hydrogen bonds between residues with closely
matched pKa values are stronger than those between residues
whose pKa values differ greatly, we may reasonably expect
thiazoline-derived inhibitors to more tightly bind to Asp174 than
PUGNAc-derived inhibitors. From the perspective of Asp174-
binding, thiazoline-derived analogues will therefore be better
transition state analogues than PUGNAc-derived inhibitors,
which possess greater ground state character in this particular
interaction.
Conclusion
Using three approaches, including linear free energy correla-
tions, X-ray crystallographic analyses, and computational
modeling, we find that NAG-thiazoline is a TS analogue for
the human O-GlcNAcase catalyzed hydrolysis ofâ-glu-
cosaminides while PUGNAc is either a poor TS analogue or a
serendipitous binding inhibitor. These observations are surprising
in view of the conventional approaches used in the design of
TS analogues of glycoside hydrolases. Specifically, PUGNAc,
which incorporates a traditional transition state design feature,
an sp2-hybridized anomeric center, is a poor TS mimic. NAG-
thiazoline, which has an sp3-hybridized anomeric center, is a
good TS analogue even though such a geometry is not
considered TS-like. It may appear counterintuitive that NAG-
thiazoline, given the tetrahedral geometry of its anomeric center,
should resemble the transition state for the hydrolysis of an
acetal since these transition states are widely perceived as
dissociative with significant oxocarbenium ion-like character.
It seems more obvious that NAG-thiazoline may resemble the
oxazoline structure found further along the reaction coordinate
and be more of a mimic of a high-energy oxazoline intermediate.
However, the C-S bond length of the thiazoline (1.86 Å) is
considerably longer than the C-O bond length (1.45 Å)
expected for the corresponding oxazoline. This longer bond
(62) Porter, G. R.; Rydon, H. N.; Schofield, J. A. Nature 1958, 182, 927.
(63) Kraulis, P. J. J. Appl. Crystallogr. 1991, 24, 946-950.
(64) Esnouf, R. M. J. Mol. Graphics Modell. 1997, 15, 132-134.
 
distance results in distortion of the pyranose ring of the
thiazoline and mimics a bond order of 0.26 between the
nucleophilic carbonyl oxygen and the anomeric center; a bond
order consistent with the significant nucleophilic participation
established previously.9 Crystallographic studies, computation-
ally determined structures, and molecular electrostatic potential
surfaces for NAG-thiazoline- and PUGNAc-based inhibitors of
humanO-GlcNAcase support this view. On the basis of these
qualitative MEPs, thiazoline-derivedO-GlcNAcase inhibitors
and related structures appear to be a better framework for
capturing a substantial fraction of the transition state binding
energy used by the enzyme when compared to PUGNAc-derived
inhibitors. These collective results, in combination with earlier
kinetics studies, also suggest late transition state poise for this
electrophilic migration mechanism with significant nucleophilic
participation and essentially no involvement of the leaving
groupsan observation consistent with studies of some of the
N-ribosyl hydrolases. This improved understanding of the
reaction coordinate adopted by humanO-GlcNAcase, however
qualitative, should provide the basis for the development and
refinement of transition state analogues of humanO-GlcNAcase
having optimized geometries.
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